tiprankstipranks
BioNTech SE (DE:22UA)
XETRA:22UA
Holding DE:22UA?
Track your performance easily

BioNTech SE (22UA) Income Statement

32 Followers

BioNTech SE Income Statement

Last quarter (Q4 2023), BioNTech SE's total revenue was €―, a decrease of -100.00% from the same quarter last year. In Q4, BioNTech SE's net income was €―. See BioNTech SE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 3.20B€ 3.82B€ 17.31B€ 18.98B€ 482.30M€ 108.59M
Cost of Revenue
€ 1.16B€ 599.80M€ 3.00B€ 2.91B€ 59.30M€ 17.36M
Gross Profit
€ 2.03B€ 3.22B€ 14.32B€ 16.07B€ 423.00M€ 91.23M
Operating Expense
€ 110.30M€ 2.36B€ 2.01B€ -200.10M€ 755.90M€ 277.51M
Operating Income
€ 1.92B€ 858.90M€ 12.30B€ 14.92B€ -332.90M€ -186.29M
Net Non Operating Interest Income Expense
€ -4.30M€ 357.60M€ 29.60M€ -25.80M€ 1.60M€ -174.93M
Other Income Expense
€ 401.30M€ -267.00M€ 620.70M€ -156.30M€ -15.20M€ -1.55M
Pretax Income
€ 2.32B€ 1.19B€ 12.95B€ 15.05B€ -381.10M€ -361.22M
Tax Provision
€ 647.30M€ 255.80M€ 3.52B€ 4.75B€ -161.00M€ -268.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
€ 1.67B€ 930.30M€ 9.43B€ 10.29B€ 15.20M€ -361.07M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
€ 1.27B€ 2.96B€ 5.01B€ 4.60B€ 815.20M€ 294.88M
Net Income From Continuing And Discontinued Operation
€ 1.67B€ 930.30M€ 9.43B€ 10.29B€ 15.20M€ -361.07M
Normalized Income
€ 1.38B-----
Interest Expense
€ 5.80M-----
EBIT
€ 2.33B-€ 12.30B€ 14.93B€ -143.80M€ -361.22M
EBITDA
€ 2.36B-€ 12.43B€ 15.00B€ -105.10M€ -327.32M
Currency in EUR

BioNTech SE Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis